Literature DB >> 28674987

Neurodegeneration and Pathology in Epilepsy: Clinical and Basic Perspectives.

Jordan S Farrell1, Marshal D Wolff1, G Campbell Teskey2.   

Abstract

Epilepsy is commonly associated with a number of neurodegenerative and pathological alterations in those areas of the brain that are involved in repeated electrographic seizures. These most prominently include neuron loss and an increase in astrocyte number and size but may also include enhanced blood-brain barrier permeability, the formation of new capillaries, axonal sprouting, and central inflammation. In animal models in which seizures are either repeatedly elicited or are self-generated, a similar set of neurodegenerative and pathological alterations in brain anatomy are observed. The primary causal agent responsible for these alterations may be the cascade of events that follow a seizure and lead to an hypoperfusion/hypoxic episode. While epilepsy has long and correctly been considered an electrical disorder, the vascular system likely plays an important causal role in the neurodegeneration and pathology that occur as a consequence of repeated seizures.

Entities:  

Keywords:  Astrocyte hypertrophy; Epilepsy; Hypoperfusion; Hypoxia; Ischemia; Neuronal death; Seizures

Mesh:

Year:  2017        PMID: 28674987     DOI: 10.1007/978-3-319-57193-5_12

Source DB:  PubMed          Journal:  Adv Neurobiol


  17 in total

Review 1.  Review: The past, present and future challenges in epilepsy-related and sudden deaths and biobanking.

Authors:  M Thom; M Boldrini; E Bundock; M N Sheppard; O Devinsky
Journal:  Neuropathol Appl Neurobiol       Date:  2018-02       Impact factor: 8.090

2.  Hippocampal astrocytic neogenin regulating glutamate uptake, a critical pathway for preventing epileptic response.

Authors:  Dong Sun; Zhi-Bing Tan; Xiang-Dong Sun; Zhi-Peng Liu; Wen-Bing Chen; Leena Milibari; Xiao Ren; Ling-Ling Yao; Daehoon Lee; Chen Shen; Jin-Xiu Pan; Zhi-Hui Huang; Lin Mei; Wen-Cheng Xiong
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-20       Impact factor: 11.205

3.  Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment.

Authors:  Itzel Jatziri Contreras-García; Gisela Gómez-Lira; Bryan Víctor Phillips-Farfán; Luz Adriana Pichardo-Macías; Mercedes Edna García-Cruz; Juan Luis Chávez-Pacheco; Julieta G Mendoza-Torreblanca
Journal:  Brain Sci       Date:  2021-04-23

Review 4.  The Effect of Metformin in Experimentally Induced Animal Models of Epileptic Seizure.

Authors:  Ebrahim M Yimer; Awol Surur; Dawit Zewdu Wondafrash; Abadi Kahsu Gebre
Journal:  Behav Neurol       Date:  2019-02-04       Impact factor: 3.342

5.  TRPV4-induced inflammatory response is involved in neuronal death in pilocarpine model of temporal lobe epilepsy in mice.

Authors:  Zhouqing Wang; Li Zhou; Dong An; Weixing Xu; Chunfeng Wu; Sha Sha; Yingchun Li; Yichao Zhu; Aidong Chen; Yimei Du; Lei Chen; Ling Chen
Journal:  Cell Death Dis       Date:  2019-05-16       Impact factor: 8.469

6.  Diverged morphology changes of astrocytic and neuronal primary cilia under reactive insults.

Authors:  Ashley Sterpka; Juan Yang; Matthew Strobel; Yuxin Zhou; Connor Pauplis; Xuanmao Chen
Journal:  Mol Brain       Date:  2020-03-02       Impact factor: 4.041

7.  The Neuroprotective Effect of miR-136 on Pilocarpine-Induced Temporal Lobe Epilepsy Rats by Inhibiting Wnt/β-Catenin Signaling Pathway.

Authors:  Hongxia Cui; Weihao Zhang
Journal:  Comput Math Methods Med       Date:  2022-02-26       Impact factor: 2.238

Review 8.  Bioenergetic Mechanisms of Seizure Control.

Authors:  Richard Kovács; Zoltan Gerevich; Alon Friedman; Jakub Otáhal; Ofer Prager; Siegrun Gabriel; Nikolaus Berndt
Journal:  Front Cell Neurosci       Date:  2018-10-08       Impact factor: 5.505

9.  microRNA-182 Negatively Influences the Neuroprotective Effect of Apelin Against Neuronal Injury in Epilepsy.

Authors:  Han Dong; Bin Dong; Na Zhang; Songyan Liu; Huiying Zhao
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-30       Impact factor: 2.570

10.  Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro-Oxidative Stress.

Authors:  Meghan Gage; Marson Putra; Logan Wachter; Kylie Dishman; Megan Gard; Crystal Gomez-Estrada; Thimmasettappa Thippeswamy
Journal:  Antioxidants (Basel)       Date:  2021-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.